Overview. GC-MS combines chromatographic separation with mass-spectral identification and is particularly valuable for volatile and semi-volatile compounds. In cannabis testing, its major applications include residual solvents, terpene profiling and selected contaminants. Method suitability depends heavily on sample preparation and the effect of inlet heat on cannabinoids.
When GC-MS is appropriate
GC-MS is well suited to volatile analytes that can be introduced reproducibly into the gas phase. Headspace GC-MS is commonly used for residual solvents, while direct or headspace approaches may be used for terpenes. It is less suitable for intact acidic cannabinoids unless derivatisation or deliberate conversion is part of the method.
Thermal conversion of cannabinoids
The heated inlet can decarboxylate THCA, CBDA and other acidic cannabinoids. A method that reports THC after hot injection may therefore measure both native THC and converted THCA. This must be understood before interpreting results.
Headspace method development
Vial size, sample mass, diluent, salt, equilibration temperature, time and agitation influence volatile recovery. Flower, oils and extracts partition solvents differently and may require matrix-specific preparation.
Mass-spectral identification
Retention time alone is insufficient where co-elution is possible. Target and qualifier ions, ion ratios and spectral libraries support identity. Library matches should be reviewed critically because related terpenes may produce similar spectra.
Calibration and internal standards
Calibration should cover the intended range and account for matrix behaviour. Internal standards can correct injection and preparation variability, but they must not interfere with target analytes.
Validation and routine controls
Specificity, accuracy, precision, linearity, range, reporting limit, carryover and robustness should be demonstrated. Routine sequences should include blanks, standards, controls and defined criteria for ion ratios and calibration.
Common failures
Frequent problems include leaking headspace vials, carryover after high standards, inappropriate library acceptance, unstable terpene standards and failure to assess matrix recovery.
Practical reference table
| Application | Preferred sample introduction | Key control |
|---|---|---|
| Residual solvents in oil | Headspace | Equilibration and matrix recovery |
| Residual solvents in flower | Headspace | Homogenisation and vial sealing |
| Terpene profile | Headspace or direct injection | Volatile loss and identification |
| Selected contaminants | Targeted GC-MS/SIM | Sensitivity and interference |
| Cannabinoids | Usually LC preferred | Avoid unrecognised thermal conversion |
Control and decision path
Frequently asked questions
Why is GC-MS useful for residual solvents?
It separates volatile compounds from much of the non-volatile cannabis matrix.
Can GC-MS measure THCA directly?
Only with an appropriate method such as derivatisation; otherwise inlet heat can cause decarboxylation.
Why use qualifier ions?
They provide additional evidence that the detected peak is the intended analyte.
What causes headspace variability?
Vial sealing, sample mass, temperature, equilibration time and matrix partitioning.
Is a library match enough for identification?
No. Retention behaviour, ion ratios and method criteria should also be considered.
Primary references and guidance
- ICH Q2(R2)
- ICH Q14
- EU GMP Part I, Chapter 6
- European Pharmacopoeia 2.2.28, Gas Chromatography
- USP <467>, Residual Solvents
- ICH Q3C
- ISO 17025
- Relevant validated method and pharmacopoeial requirements
Confirm the current effective revision and national applicability before operational or regulatory use.